Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Entasis Therapeutics Holdings Inc. - Common Stock (NQ:ETTX)

N/A UNCHANGED
Last Price Updated: 3:59 PM EDT, Jul 8, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 2.190 (56)
Ask (Size) 2.200 (64)
Prev. Close 2.190
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 47,851,779
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022
Six abstracts selected for presentation, including three oral presentations 
From Entasis Therapeutics Holdings Inc.
Via GlobeNewswire
Over $42 Million Bet On This Biotechnology Stock? 4 Penny Stocks Insiders are Buying
US producer prices likely to rise 0.8% on the month in June to match the previous month’s growth. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga

Performance

More News

Read More
Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.
From Innoviva, Inc.
Via Business Wire
Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share
Via Benzinga
Scott+Scott Attorneys at Law LLP Investigates Innoviva Buyout of Entasis – ETTX
From Scott+Scott Attorneys at Law LLP
Via Business Wire
58 Biggest Movers From Yesterday
Via Benzinga
ENTASIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Entasis Therapeutics Holdings Inc. - ETTX
From Kahn Swick & Foti, LLC
Via Business Wire
ETTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Entasis Therapeutics Holdings Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
Innoviva to Acquire Entasis Therapeutics
From Innoviva, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022
Via Benzinga
Entasis Therapeutics Hldg: Q1 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Wednesday Top Stock News: 8 Analyst Upgrades and Downgrades Today
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 4, 2022
Via Benzinga
Recap: Entasis Therapeutics Q4 Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
54 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
30 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
Week In Review: China's Hansoh Signs Two siRNA Deals Worth $1.7 Billion
Via Talk Markets
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Entasis Therapeutics Holdings Inc. - Common Stock publicly traded?
Yes, Entasis Therapeutics Holdings Inc. - Common Stock is publicly traded.
What exchange does Entasis Therapeutics Holdings Inc. - Common Stock trade on?
Entasis Therapeutics Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Entasis Therapeutics Holdings Inc. - Common Stock?
The ticker symbol for Entasis Therapeutics Holdings Inc. - Common Stock is ETTX on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.